RxDoctor Payments Data

Jennifer Duick

Family · Phoenix, AZNPI 1881016459

Payments from drug & device makers

$1,722in general payments, 2019–2025

Across 48 payments — averaging $35.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$727
  • Eisai Inc.$152
  • Axsome Therapeutics, Inc.$138
  • Novo Nordisk$125
  • Exact Sciences$75
  • Lilly USA, LLC$69
  • plus $436 from 12 others

What the payments were for

  • Food & beverage$1,722100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,722 in reported general payments places this provider in the 75th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$20,235
Medicare patients
93
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$23,234
Rivastigmine15$2,110
Albuterol Sulfate HfaAlbuterol Sulfate20$1,166
Levothyroxine Sodium50$436
Atorvastatin Calcium47$426
Potassium Chloride31$325
Memantine Hcl15$321
Trazodone Hcl32$264
Metoprolol Succinate17$258
Fluticasone Propionate17$234
Duloxetine Hcl11$226
Losartan Potassium23$206
Lisinopril31$204
Tramadol Hcl27$189
Amlodipine Besylate30$175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$56$23,23431 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,119 family providers in Arizona.

Other family in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →